Multiplikator Forward P/S: TransMedics Group, Inc. (TMDX)
TransMedics Group (TMDX) growth is driven by the expansion of organ preservation systems and logistical precision. A monopoly position in air transport ensures a stable cash flow, while the uniqueness of the technology provides the pricing power to dictate service costs to the market. On GURU.Markets, the forward revenue multiple illustrates the business valuation trend, with the parameter stabilizing at 7.40, confirming the high market value of the company's innovations.
Ringkesan rincian data analitis TransMedics Organ Care System (TMDX)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal TransMedics Group|TMDX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal TransMedics Group|TMDX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku TransMedics Organ Care System|TMDX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan TransMedics|Rasio cepet transmedics.com
- rincian asil keuangan lan kelipatan valuasi:
TMDX - Penghasilan resik perusahaan|Bathi sing dikarepake TransMedics Group|TMDX - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi TransMedics Group, Inc.|TMDX - Pangali PEG|Pangali EV/EBITDA TransMedics Organ Care System|TMDX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan TransMedics|TMDX - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan transmedics.com|TMDX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep TransMedics Group
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:TMDX (TransMedics)
To select high-quality assets, it is essential for an investor to compare the current market value of a business with its future cash flows. This forward price-to-sales valuation measures the ratio of market capitalization to projected sales, which, for a market-monopolizing ecosystem like TransMedics Group (TMDX), allows for an assessment of the premium for implementing live organ storage standards through an analysis of this chart's dynamics.
Karo sapa TransMedics Group saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ATEC|Multiplikator forward rega marang pendapatan Artivion Corp AORT|Multiplikator Forward P/S ENOV (Enovis Corporation)|Multiplikator Forward P/S integralife.com IART|ESTA - Rasio rega marang prakiraan pendapatan|BBNX: Rasio rega marang prakiraan pendapatan|IRMD (Iradimed) - Multiplikator forward rega marang pendapatan|Embecta Health - Rega forward marang dodolan|TNDM (Tandem Diabetes Care) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep axogeninc.com AXGN|Rasio rega marang prakiraan pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Prakiraan rega marang pendapatan|Bioventus Corp - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake blade.com SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Inc)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI (vivani.com) - Multiplikator forward rega marang pendapatan|XTNT: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|MODD: Rega forward marang dodolan|Multiplikator Forward P/S MYO|Multiplikator Forward P/S Envoy Medical Inc (COCH)|Rasio rega marang prakiraan pendapatan Vivos Therapeutics VVOS|NVNO: Kapitalisasi marang prakiraan pendapatan|SINT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Tenon Medical Inc. TNON|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Autonomix Medical|IVF (INVO Fertility Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep bonebiologics.com BBLG|Multiplikator Forward P/S AXNX|BIOLASE Inc. - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S DYNT (Dynatronics)|Rasio kapitalisasi marang dodolan sing dikarepake Paragon 28 Inc. (FNA)|INVO Bio - Multiplikator Forward P/S
